$23.23 3.43 (+17.34%)
2/10/2012 4:00 PM

Pharmacyclics, Inc. (NASDAQ:PCYC)

CAPS Rating: 1 out of 5

A pharmaceutical company focused on the development of products that improve existing therapeutic approaches to cancer and other diseases.

Featured Broker Partners


Advertisement